The RECELL System has had CE Mark approval since 2005 so that's why it's stated at the bottom of all the press releases. I'm sure they'll update the market if/when they receive CE Mark approval for RECELL GO because it's an important milestone for the international expansion.
Today's announcement means that they won't be providing preliminary numbers for Q3. My misinterpretation of that is they are within the $19-20M revenue guidance for Q324 because that's what happened last quarter when Q2 revenue came in at the upper-end of guidance. If they didn't meet guidance, they would have provided an update like they did when they missed Q124 revenue guidance.
Ann: AVITA Medical to Announce Third Quarter 2024 Results, page-9
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.96 |
Change
0.140(3.66%) |
Mkt cap ! $276.7M | |||
| Open | High | Low | Value | Volume |
| $3.92 | $3.98 | $3.86 | $1.203M | 306.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 6132 | $3.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.96 | 5299 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |